161 related articles for article (PubMed ID: 7994759)
1. Suppression of HIV replication by CD8+ cell clones derived from HIV-infected and uninfected individuals.
Hsueh FW; Walker CM; Blackbourn DJ; Levy JA
Cell Immunol; 1994 Dec; 159(2):271-9. PubMed ID: 7994759
[TBL] [Abstract][Full Text] [Related]
2. [CD8+ cell noncytotoxic antiviral response (CNAR) to HIV in nosocomial HIV-infected individuals].
Yuan L; Ma LY; Zang XH; Meng XD; Peng H; Zhao QB; Xing H; Shao YM
Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2008 Jun; 22(3):195-7. PubMed ID: 19031701
[TBL] [Abstract][Full Text] [Related]
3. CD8+ cell-derived anti-human immunodeficiency virus inhibitory factor.
Barker E
J Infect Dis; 1999 May; 179 Suppl 3():S485-8. PubMed ID: 10099125
[TBL] [Abstract][Full Text] [Related]
4. Natural killer cells from human immunodeficiency virus (HIV)-infected individuals are an important source of CC-chemokines and suppress HIV-1 entry and replication in vitro.
Oliva A; Kinter AL; Vaccarezza M; Rubbert A; Catanzaro A; Moir S; Monaco J; Ehler L; Mizell S; Jackson R; Li Y; Romano JW; Fauci AS
J Clin Invest; 1998 Jul; 102(1):223-31. PubMed ID: 9649576
[TBL] [Abstract][Full Text] [Related]
5. Identification of multiple and distinct CD8+ T cell suppressor activities: dichotomy between infected and uninfected individuals, evolution with progression of disease, and sensitivity to gamma irradiation.
Barker TD; Weissman D; Daucher JA; Roche KM; Fauci AS
J Immunol; 1996 Jun; 156(11):4476-83. PubMed ID: 8666823
[TBL] [Abstract][Full Text] [Related]
6. Antigen-specific beta-chemokine production and CD8 T-cell noncytotoxic antiviral activity in HIV-2-infected individuals.
Ahmed RK; Norrgren H; da Silva Z; Blaxhult A; Fredriksson EL; Biberfeld G; Andersson S; Thorstensson R
Scand J Immunol; 2005 Jan; 61(1):63-71. PubMed ID: 15644124
[TBL] [Abstract][Full Text] [Related]
7. Apoptotic killing of CD4+ T lymphocytes in HIV-1-infected PHA-stimulated PBL cultures is mediated by CD8+ LAK cells.
Wang L; Klimpel GR; Planas JM; Li H; Cloyd MW
Virology; 1998 Feb; 241(2):169-80. PubMed ID: 9499792
[TBL] [Abstract][Full Text] [Related]
8. Productive human immunodeficiency virus type 1 infection in peripheral blood predominantly takes place in CD4/CD8 double-negative T lymphocytes.
Kaiser P; Joos B; Niederöst B; Weber R; Günthard HF; Fischer M
J Virol; 2007 Sep; 81(18):9693-706. PubMed ID: 17609262
[TBL] [Abstract][Full Text] [Related]
9. CD38 expression on CD8 T cells has a weak association with CD4 T-cell recovery and is a poor marker of viral replication in HIV-1-infected patients on antiretroviral therapy.
Steel A; John L; Shamji MH; Henderson DC; Gotch FM; Gazzard BG; Kelleher P
HIV Med; 2008 Feb; 9(2):118-25. PubMed ID: 18257774
[TBL] [Abstract][Full Text] [Related]
10. High SDF-1 expression in HIV-1 carriers does not correlate with CD8+ T-cell-mediated suppression of viral replication.
Ohashi T; Arai M; Kato H; Kubo M; Fujii M; Yamamoto N; Iwamoto A; Kannagi M
Virology; 1998 May; 244(2):467-72. PubMed ID: 9601514
[TBL] [Abstract][Full Text] [Related]
11. Human and simian immunodeficiency virus-infected chimpanzees do not have increased intracellular levels of beta-chemokines in contrast to infected humans.
Ondoa P; Vereecken C; Fransen K; Colebunders R; van der Groen G; Heeney JL; Kestens L
J Med Virol; 2003 Mar; 69(3):297-305. PubMed ID: 12526038
[TBL] [Abstract][Full Text] [Related]
12. In vitro induction of HIV-1 replication in resting CD4(+) T cells derived from individuals with undetectable plasma viremia upon stimulation with human T-cell leukemia virus type I.
Moriuchi H; Moriuchi M
Virology; 2000 Dec; 278(2):514-9. PubMed ID: 11118373
[TBL] [Abstract][Full Text] [Related]
13. Interleukin-9 receptor alpha chain mRNA formation in CD8+ T cells producing anti-human immunodeficiency virus type 1 substance(s).
Hossain MM; Tsuchie H; Detorio MA; Shirono H; Hara C; Nishimoto A; Saji A; Koga J; Takata N; Maniar JK; Saple DG; Taniguchi K; Kageyama S; Ichimura H; Kurimura T
Acta Virol; 1998 Feb; 42(1):47-53. PubMed ID: 9645243
[TBL] [Abstract][Full Text] [Related]
14. Acute human immunodeficiency virus replication causes a rapid and persistent impairment of Vgamma9Vdelta2 T cells in chronically infected patients undergoing structured treatment interruption.
Martini F; Poccia F; Goletti D; Carrara S; Vincenti D; D'Offizi G; Agrati C; Ippolito G; Colizzi V; Pucillo LP; Montesano C
J Infect Dis; 2002 Sep; 186(6):847-50. PubMed ID: 12198622
[TBL] [Abstract][Full Text] [Related]
15. CD8 lymphocytes in HIV infection: helpful and harmful.
Famularo G; Moretti S; Marcellini S; Nucera E; De Simone C
J Clin Lab Immunol; 1997; 49(1):15-32. PubMed ID: 9819670
[TBL] [Abstract][Full Text] [Related]
16. Derivation of infectious HIV-1 molecular clones with LTR mutations: sensitivity to the CD8+ cell noncytotoxic anti-HIV response.
Bonneau KR; Ng S; Foster H; Choi KB; Berkhout B; Rabson A; Mackewicz CE; Levy JA
Virology; 2008 Mar; 373(1):30-8. PubMed ID: 18086484
[TBL] [Abstract][Full Text] [Related]
17. Dual function of a human immunodeficiency virus (HIV)-specific cytotoxic T-lymphocyte clone: inhibition of HIV replication by noncytolytic mechanisms and lysis of HIV-infected CD4+ cells.
Buseyne F; Février M; Garcia S; Gougeon ML; Rivière Y
Virology; 1996 Nov; 225(1):248-53. PubMed ID: 8918556
[TBL] [Abstract][Full Text] [Related]
18. HIV-1-infected children on HAART: immunologic features of three different levels of viral suppression.
Zaccarelli-Filho CA; Ono E; Machado DM; Brunialti M; Succi RC; Salomão R; Kallás EG; de Moraes-Pinto MI
Cytometry B Clin Cytom; 2007 Jan; 72(1):14-21. PubMed ID: 17041945
[TBL] [Abstract][Full Text] [Related]
19. High levels of human immunodeficiency virus infection of CD8 lymphocytes expressing CD4 in vivo.
Cochrane A; Imlach S; Leen C; Scott G; Kennedy D; Simmonds P
J Virol; 2004 Sep; 78(18):9862-71. PubMed ID: 15331721
[TBL] [Abstract][Full Text] [Related]
20. Presence of human immunodeficiency virus-1-specific CD4 and CD8 cellular immune responses in children with full or partial virus suppression.
Papasavvas E; Sandberg JK; Rutstein R; Moore EC; Mackiewicz A; Thiel B; Pistilli M; June RR; Jordan KA; Gross R; Maino VC; Nixon DF; Montaner LJ
J Infect Dis; 2003 Sep; 188(6):873-82. PubMed ID: 12964119
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
